Metabonomic analysis of liver tissue from BALB/c mice with D-galactosamine/lipopolysaccharide-induced acute hepatic failure
- PMID: 23627910
- PMCID: PMC3644245
- DOI: 10.1186/1471-230X-13-73
Metabonomic analysis of liver tissue from BALB/c mice with D-galactosamine/lipopolysaccharide-induced acute hepatic failure
Abstract
Background: Compared with biofluids, target tissues and organs more directly reflect the pathophysiological state of a disease process. In this study, a D-galactosamine (GalN) / lipopolysaccharide (LPS)-induced mouse model was constructed to investigate metabonomics of liver tissue and directly characterize metabolic changes in acute liver failure (ALF).
Methods: After pretreatment of liver tissue, gas chromatography coupled to time-of-flight mass spectrometry (GC/TOFMS) was used to separate and identify the liver metabolites. Partial least squares--discriminant analysis models were constructed to separate the ALF and control groups and to find those compounds whose liver levels differed significantly between the two groups.
Results: Distinct clustering was observed between the ALF and control mice. Fifty-eight endogenous metabolites were identified. Compared with the control mice, many metabolites, including sugars, amino acids, fatty acids, and organic acids, underwent significant changes in the ALF group, some of which differed from changes observed in plasma. Significant reduction of some important intermediate metabolites indicates that production of ketone bodies, the tricarboxylic acid and urea cycles, gluconeogenesis, glycolysis and pentose phosphate pathways are inhibited after GalN/LPS administration.
Conclusions: GC/TOFMS can be a powerful technique to perform metabonomic studies of liver tissue. GalN/LPS treatment can severely disturb substance metabolism in the liver, with different effects on metabolites compared with those observed in the plasma.
Figures


Similar articles
-
Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.Liver Transpl. 2008 Nov;14(11):1620-31. doi: 10.1002/lt.21578. Liver Transpl. 2008. PMID: 18975270
-
Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure.J Proteome Res. 2007 Jun;6(6):2161-7. doi: 10.1021/pr0606326. Epub 2007 May 12. J Proteome Res. 2007. PMID: 17497905
-
Comparative Proteomic Analyses of the Liver in D-Galactosamine-Sensitized Mice Treated with Different Toll-Like Receptor Agonists.Proteomics. 2020 Apr;20(8):e1900393. doi: 10.1002/pmic.201900393. Epub 2020 Apr 2. Proteomics. 2020. PMID: 32131144
-
[Role of autophagy in acute liver failure induced by D-galactosamine/lipopolysaccharide in mice].Zhonghua Gan Zang Bing Za Zhi. 2016 Aug 20;24(8):608-613. doi: 10.3760/cma.j.issn.1007-3418.2016.08.010. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27788709 Chinese.
-
Metabonomics and its role in amino acid nutrition research.Front Biosci (Landmark Ed). 2011 Jun 1;16(7):2451-60. doi: 10.2741/3865. Front Biosci (Landmark Ed). 2011. PMID: 21622188 Review.
Cited by
-
Detecting serum and urine metabolic profile changes of CCl4-liver fibrosis in rats at 12 weeks based on gas chromatography-mass spectrometry.Exp Ther Med. 2017 Aug;14(2):1496-1504. doi: 10.3892/etm.2017.4668. Epub 2017 Jun 26. Exp Ther Med. 2017. PMID: 28810615 Free PMC article.
-
Estrogen-Related Receptor γ Agonist DY131 Ameliorates Lipopolysaccharide-Induced Acute Liver Injury.Front Pharmacol. 2021 Apr 23;12:626166. doi: 10.3389/fphar.2021.626166. eCollection 2021. Front Pharmacol. 2021. PMID: 33967760 Free PMC article.
-
Serum Metabolomic Profiling to Reveal Potential Biomarkers for the Diagnosis of Fatty Liver Hemorrhagic Syndrome in Laying Hens.Front Physiol. 2021 Feb 9;12:590638. doi: 10.3389/fphys.2021.590638. eCollection 2021. Front Physiol. 2021. PMID: 33633583 Free PMC article.
-
The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure.J Clin Biochem Nutr. 2022 Jan;70(1):54-63. doi: 10.3164/jcbn.21-50. Epub 2021 Jun 26. J Clin Biochem Nutr. 2022. PMID: 35068682 Free PMC article.
-
A systems pharmacology-oriented discovery of a new therapeutic use of the TCM formula Liuweiwuling for liver failure.Sci Rep. 2018 Apr 4;8(1):5645. doi: 10.1038/s41598-018-21515-6. Sci Rep. 2018. PMID: 29618826 Free PMC article.
References
-
- Gunning K. Hepatic failure. Anaesth Intens Care. 2009;10(3):124–126. doi: 10.1016/j.mpaic.2008.12.002. - DOI
-
- Hadem J, Tacke F, Bruns T, Langgartner J, Strnad P, Denk GU, Fikatas P, Manns MP, Hofmann WP, Gerken G, Grünhage F, Umgelter A, Trautwein C, Canbay A. Acute Liver Failure Study Group Germany. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol. 2012;10(6):664–669. doi: 10.1016/j.cgh.2012.02.016. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous